Quest Diagnostics Incorporated (DGX)vsIQVIA Holdings Inc (IQV)
DGX
Quest Diagnostics Incorporated
$233.72
+0.76%
HEALTHCARE · Cap: $25.72B
IQV
IQVIA Holdings Inc
$228.20
-2.21%
HEALTHCARE · Cap: $38.68B
Smart Verdict
WallStSmart Research — data-driven comparison
IQVIA Holdings Inc generates 47% more annual revenue ($16.98B vs $11.56B). DGX leads profitability with a 9.2% profit margin vs 8.1%. IQV appears more attractively valued with a PEG of 0.98. DGX earns a higher WallStSmart Score of 60/100 (C).
DGX
Buy60
out of 100
Grade: C
IQV
Buy55
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for DGX.
Margin of Safety
+11.9%
Fair Value
$201.09
Current Price
$228.20
$27.11 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Every $100 of equity generates 22 in profit
Growing faster than its price suggests
Areas to Watch
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Earnings declined 0.6%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : DGX
Revenue growth of 10.2% demonstrates continued momentum.
Bull Case : IQV
The strongest argument for IQV centers on Return on Equity, PEG Ratio. PEG of 0.98 suggests the stock is reasonably priced for its growth.
Bear Case : DGX
The primary concerns for DGX are PEG Ratio.
Bear Case : IQV
The primary concerns for IQV are P/E Ratio, Piotroski F-Score, EPS Growth. Debt-to-equity of 2.58 is elevated, increasing financial risk.
Key Dynamics to Monitor
IQV carries more volatility with a beta of 1.20 — expect wider price swings.
DGX is growing revenue faster at 10.2% — sustainability is the question.
IQV generates stronger free cash flow (491M), providing more financial flexibility.
Monitor DIAGNOSTICS & RESEARCH industry trends, competitive dynamics, and regulatory changes.
Bottom Line
DGX scores higher overall (60/100 vs 55/100) and 10.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Quest Diagnostics Incorporated
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
IQVIA Holdings Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?